Mumbai, Jan. 8 -- Securities in F&O Ban:

Shares of Steel Authority of India(SAIL) and Sammaan Capital are banned from F&O trading on 8 January 2026.

Stocks to Watch:

Gland Pharma has received an approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) filed for Olopatadine Hydrochloride Ophthalmic Solution. The said drug is indicated for the treatment of ocular itching associated with allergic conjunctivitis.

Angel One is scheduled to meet on Thursday, 15 January, 2026 to consider sub-division/split of existing equity shares having face value of Rs 10 each, fully paid up.

Tata Steel's India crude steel production stood at 6.34 million tons in Q3 FY26, up 12% QoQ and YoY, pri...